PERTAMEDIKA PERTAMINA BINA MEDIKA
PERTAMEDIKA PERTAMINA BINA MEDIKA, commonly referred to as Pertamedika, is a prominent healthcare provider headquartered in Indonesia. Established in 2014, the company has rapidly evolved to become a key player in the healthcare industry, primarily focusing on hospital management, medical services, and health insurance. With operations spanning across major regions in Indonesia, Pertamedika is dedicated to delivering high-quality healthcare solutions that cater to diverse patient needs. The company offers a range of core services, including inpatient and outpatient care, diagnostic services, and specialised medical treatments, distinguished by its commitment to patient-centric care and advanced medical technology. Recognised for its innovative approach and operational excellence, Pertamedika has achieved significant milestones, positioning itself as a trusted name in the Indonesian healthcare landscape.
DitchCarbon Score
How does PERTAMEDIKA PERTAMINA BINA MEDIKA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PERTAMEDIKA PERTAMINA BINA MEDIKA's score of 24 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PERTAMEDIKA PERTAMINA BINA MEDIKA's reported carbon emissions
In 2023, PERTAMEDIKA PERTAMINA BINA MEDIKA reported significant carbon emissions, totalling approximately 3,190,791,000 kg CO2e for Scope 1 and about 62,058,424,000 kg CO2e for Scope 2. This reflects a continued commitment to managing their carbon footprint, with emissions from Scope 1 and Scope 2 being disclosed for the years 2021 to 2023. Comparatively, in 2022, the organisation's emissions were about 2,374,599,000 kg CO2e for Scope 1 and approximately 53,490,830,000 kg CO2e for Scope 2, while in 2021, they recorded around 2,010,201,000 kg CO2e for Scope 1 and about 52,617,524,000 kg CO2e for Scope 2. This data indicates a trend of increasing emissions over the three years, particularly in Scope 2. PERTAMEDIKA PERTAMINA BINA MEDIKA has set near-term climate commitments to effectively manage emissions for both Scope 1 and Scope 2, with a target timeframe from 2023 to 2025. While specific reduction percentages have not been disclosed, the organisation is focused on achieving net-zero emissions through these initiatives. The emissions intensity per patient has also been reported, with values of 2.73 in 2023, 2.59 in 2022, and 2.87 in 2021, indicating a commitment to improving efficiency in their operations. Overall, PERTAMEDIKA PERTAMINA BINA MEDIKA is actively working towards reducing its carbon emissions and enhancing sustainability practices within the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 2,010,201,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 52,617,524,000 | 00,000,000,000 | 00,000,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
PERTAMEDIKA PERTAMINA BINA MEDIKA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
